NR3C2 and familial dilated cardiomyopathy: The DCM group used significantly more medications compared to the NCCM group, including beta-blockers, ACE/ARB inhibitors, diuretics, and aldosterone receptor antagonists, along with a lower mean LV ejection fraction (LVEF) in DCM patients compared to NCCM patients: 34 ± 12% vs. 42 ± 11%; p = 0.004.